Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 41 ~ 60 of 26060, Page 3 of 1303
41. Rising to the challenge of malaria eradication
08/23/2019 WHO
42. World Bank and WHO Statement on Partnership & Deployment of Financing to WHO for Ebola Response in DRC
08/22/2019 WHO
43. RSNA Announces New Global Learning Centers Program
OAK BROOK, Ill. (August 22, 2019) ? The Radiological Society of North America (RSNA) is launching a new RSNA Global Learning Centers (GLC) program beginning in 2020. By partnering with established radiology departments based in low- or middle-income countries to create the learning centers, RSNA aims to improve radiology education and patient care around the world.
08/22/2019 Radiological Society of North America
44. Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer
Pooled Overall Survival (OS) Data from Three Trials with KEYTRUDA® (pembrolizumab) Plus Chemotherapy in Subgroup of Patients with Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Do Not Express PD-L1 / New KEYTRUDA Monotherapy Data in NSCLC Include Three-Year OS Data from Phase 3 KEYNOTE-024 and First-Time Data in Chinese Patients from Phase 3 KEYNOTE-042
08/22/2019 MERCK
45. Three years without a case of wild polio virus, Government of Nigeria warns against complacency
08/21/2019 WHO
46. Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
Pregnant women may be inadvertently exposed to a commonly used MRI contrast agent early in their pregnancy / Researchers analyzed data on U.S. pregnancies between 2006 and 2017 / Contrast agent exposure was seen in 5,457 of 4.69 million pregnancies, a number corresponding to one in 860 pregnancies
08/20/2019 Radiological Society of North America
47. Vaping Impairs Vascular Function
Vaping immediately impacts vascular function, even when the solution does not include nicotine / Researchers performed MRI exams on 31 healthy non-smoking adults before and after nicotine-free e-cigarette inhalation / In 2018 more than 3.6 million middle and high school students reported using e-cigarettes
08/20/2019 Radiological Society of North America
48. WHO Director-General underscores commitment to strengthening health in Pacific Islands
08/18/2019 WHO
49. Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease
08/16/2019 Medtronic
50. Medtronic Approved to Start Pivotal Trial to Evaluate New Extended Wear Infusion Set
Experimental Infusion Set Aims to Address Patient Burden with Comfort and Convenience Features for Insulin Pump Therapy
08/16/2019 Medtronic
51. WHO congratulates new UNAIDS Executive Director
The Director-General of the World Health Organization welcomes the appointment of Winnie Byanyima as the new Executive Director of UNAIDS.
08/15/2019 WHO
52. WHO statement urging governments to ban tobacco advertising, promotion and sponsorship at international expositions
08/15/2019 WHO
53. The surgeon who treats your ankle fracture is more important than previously recognized
Short-term complications after ankle fracture surgeries could lead to poor, long-term patient outcomes
08/15/2019 American Academy of Orthopaedic Surgeons
54. Burundi launches ebola vaccination campaign for health and front-line workers
08/14/2019 WHO
55. Abbott and Intoximeters Partner to Keep Roads Safer by Bringing Together Industry-leading Technology for Drug and Alcohol Testing
Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers / Collaboration is a major step in keeping roads safer as recreational marijuana legalization accelerates[1]
08/14/2019 Abbott
56. LYNPARZA® (olaparib) Phase 3 PAOLA-1 Trial Met Primary Endpoint as First-Line Maintenance Treatment with Bevacizumab for Advanced Ovarian Cancer
AstraZeneca and Merck’s LYNPARZA, When Added to Standard-of-Care Bevacizumab, Significantly Reduced the Risk of Disease Progression or Death in Women Who Responded to Platinum-Based Chemotherapy
08/14/2019 MERCK
57. It’s Never Too Late to Get More Exercise
Research shows that upping your exercise level can pay healthy dividends, even if you’re starting later in life.
08/01/2019 American Cancer Society
58. AI Improves Efficiency and Accuracy of Digital Breast Tomosynthesis
Researchers trained an AI system on large digital breast tomosynthesis (DBT) data sets to identify suspicious findings. / The system was tested by having 24 radiologists, including 13 breast subspecialists, each read 260 DBT examinations with and without AI assistance. / Cancer detection sensitivity and specificity increased, and reading times decreased.
07/31/2019 Radiological Society of North America
59. AI Showcase Expands and Relocates at RSNA 2019
OAK BROOK, Ill. (July 31, 2019) ? The Radiological Society of North America (RSNA) will feature an expanded artificial intelligence (AI) presence at its 105th Scientific Assembly and Annual Meeting (RSNA 2019) at McCormick Place in Chicago.
07/31/2019 Radiological Society of North America
60. FDA Approves New Monotherapy Indication for Merck’s KEYTRUDA® (pembrolizumab)
KEYTRUDA Now Approved for Recurrent Locally Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus in Patients Whose Tumors Express PD-L1 (CPS ≥10) With Disease Progression After One or More Prior Lines of Systemic Therapy
07/31/2019 MERCK
1 2 3 4 5 6 7 8 9 10
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱